Kamada (KMDA) Capital Expenditures (2013 - 2026)
Kamada's (KMDA) quarterly Capital Expenditures came in at -$973000.0 in Q1 2026, up 33.72% YoY from -$727643.4 in Q1 2025, and down 138.57% on a QoQ basis from $2.5 million in Q4 2025.
Kamada (KMDA) Capital Expenditures (2013 - 2026) Analysis & Trends
Kamada (KMDA) has 14 years of Capital Expenditures data on file, last reported at -$973000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 33.72% year-over-year to -$973000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.1 million (up 12.78% YoY) and the FY2025 annual result came in at -$9.8 million, down 603.63% from the prior year.
- Capital Expenditures fell to -$973000.0 in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $2.5 million in Q4 2025 to a low of -$3.6 million in Q3 2025.
- A 5-year average of -$836043.1 and a median of -$977000.0 in 2022 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 202.63% in 2024, down 240007.43% in 2024.
- Tracing KMDA's Capital Expenditures over 5 years: stood at -$977000.0 in 2022, then jumped by 166.12% to $646000.0 in 2023, then surged by 202.63% to $2.0 million in 2024, then gained by 29.05% to $2.5 million in 2025, then sank by 138.57% to -$973000.0 in 2026.
- The last three Capital Expenditures figures came in at -$973000.0 (Q1 2026), $2.5 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Kamada | 463.48 Mn | 434.00 Mn | 22.47 Mn | 2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Mn |
| Jun 30, 2026 | 2.11 Mn |
| Mar 31, 2026 | -973,000.00 |
| Mar 31, 2026 | -973,000.00 |
| Dec 31, 2025 | 2.52 Mn |
| Dec 31, 2025 | 2.52 Mn |
| Sep 30, 2025 | -3.59 Mn |
| Sep 30, 2025 | -3.59 Mn |
| Jun 30, 2025 | -2.01 Mn |
| Jun 30, 2025 | -2.01 Mn |
| Mar 31, 2025 | -1.47 Mn |
| Mar 31, 2025 | -1.47 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | -2.12 Mn |
| Sep 30, 2024 | -2.12 Mn |
| Jun 30, 2024 | -3.01 Mn |
| Jun 30, 2024 | -3.01 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Mar 31, 2024 | -2.68 Mn |